Confirmation of response in cancer clinical trials: A meaningless exercise?

European Journal of Cancer

Volumn 41, Issue 11, 2005, Pages 1501-1502

  Therasse, P ^a   Eisenhauer, E ^b  

^a EORTC DATA CENTER   (Belgium)

^b Clinical Trials Group   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

CANCER; DRUG MARKETING; EDITORIAL; EVIDENCE BASED MEDICINE; MEDICAL DECISION MAKING; MEDICAL LITERATURE; MEDICAL RESEARCH; PRIORITY JOURNAL; TREATMENT OUTCOME;

CLINICAL TRIALS, PHASE II; HUMANS; NEOPLASMS; TREATMENT OUTCOME;

EID: 22144440450     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2005.04.021     Document Type: Editorial

References (4)

1. J.L. Hayward, P.P. Carbone, and J.C. Heuson Assessment of response to therapy in advanced breast cancer: a project of the programme on clinical oncology of the international union against cancer, Geneva, Switzerland Cancer 39 3 1977 1289 1294
2. P. Therasse, S.G. Arbuck, and E.A. Eisenhauer New guidelines to evaluate the response to treatment in solid tumours. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada J Natl Cancer Inst 92 3 2000 205 216
3. F. Pignatti, B. Aronsson, and S. Vamvakas Clinical trials for registration in the European Union: the EMEA 5-year experience in oncology Crit Rev Oncol Hematol 42 2 2002 123 135
4. R. Dagher, J. Johnson, and G. Williams Accelerated approval of oncology products: a decade of experience J Natl Cancer Inst 96 20 2004 1500 1509